SUN Qiang is a researcher, Doctoral Supervisor, is a recipient of the National Science Fund for Distinguished Young Scholars and the Leading Talent of Scientific and Technological Innovation for Young and Middle-aged Scientists of the Ministry of Science and Technology. He has received the 2018 Tan Jiazhen Life Science Innovation Award, the 2020 WuXi AppTec Life Chemistry Research Award—Scholar Award, and the First Prize of the 2022 Shanghai Natural Science Award. He also serves as Council Member of the Chinese Association for Laboratory Animal Science, Standing Director of the Primate Laboratory Animal Specialized Committee, Council Member of the Shanghai Laboratory Animal Science Association, and Committee Member of the Biosafety Specialized Committee.

He has been dedicated to laboratory animal management and the development of technologies for constructing animal models, achieving China's first "test-tube cynomolgus monkeys" in 2007 (PNAS, 2008). He successively established a lentiviral transfection-based transgenic monkey construction technology and generated transgenic monkeys exhibiting human autism-like phenotypes (Nature, 2016); developed a maturation acceleration technology based on heterotopic testis transplantation combined with hormone injection in cynomolgus monkeys, significantly shortening the sexual maturation time of male cynomolgus monkeys (Cell Research, 2016; Natl Sci Rev, 2021); established and optimized CRISPR/Cas9-based gene editing technologies in rats, mice, and cynomolgus monkeys, generating gene knockout and knock-in animal models (Cell Research, 2017 & 2018; Nature Communications, 2018; Natl Sci Rev, 2019a); and developed a non-human primate nuclear-cytoplasmic replacement technology based on first polar body replacement (Cell Research, 2020). To address the challenges of chimerism, off-target effects, difficulties in complex genetic manipulation, non-uniform genetic backgrounds, and prolonged generation times in existing non-human primate model construction, he established, for the first time internationally, non-human primate somatic cell cloning technology (Cell, 2018), and subsequently utilized this technology to successfully generate the world's first batch of BMAL1 knockout cloned monkeys with circadian rhythm disorders (Natl Sci Rev, 2019b).